A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice ; day:8 ; month:8 ; year:2022 ; pages:1-15
Neurotherapeutics ; (8.8.2022), 1-15
- Urheber
-
Rofo, Fadi
Meier, Silvio R.
Metzendorf, Nicole G.
Morrison, Jamie I.
Petrovic, Alex
Syvänen, Stina
Sehlin, Dag
Hultqvist, Greta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-022-01283-y
- URN
-
urn:nbn:de:101:1-2022102422420837385518
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rofo, Fadi
- Meier, Silvio R.
- Metzendorf, Nicole G.
- Morrison, Jamie I.
- Petrovic, Alex
- Syvänen, Stina
- Sehlin, Dag
- Hultqvist, Greta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy